Characterization of regulatory T cells in obese omental adipose tissue in humans
EUROPEAN JOURNAL OF IMMUNOLOGY
Authors: Wu, Dan; Han, Jonathan M.; Yu, Xin; Lam, Avery J.; Hoeppli, Romy E.; Pesenacker, Anne M.; Huang, Qing; Chen, Virginia; Speake, Cate; Yorke, Ekua; Nam Nguyen; Sampath, Sharadh; Harris, David; Levings, Megan K.
Abstract
Obesity-associated visceral adipose tissue (AT) inflammation promotes insulin resistance and type 2 diabetes (T2D). In mice, lean visceral AT is populated with anti-inflammatory cells, notably regulatory T cells (Tregs) expressing the IL-33 receptor ST2. Conversely, obese AT contains fewer Tregs and more proinflammatory cells. In humans, however, there is limited evidence for a similar pattern of obesity-associated immunomodulation. We used flow cytometry and mRNA quantification to characterize human omental AT in 29 obese subjects, 18 of whom had T2D. Patients with T2D had increased proportions of inflammatory cells, including M1 macrophages, with positive correlations to body mass index. In contrast, Treg frequencies negatively correlated to body mass index but were comparable between T2D and non-T2D individuals. Compared to human thymic Tregs, omental AT Tregs expressed similar levels of FOXP3, CD25, IKZF2, and CTLA4, but higher levels of PPARG, CCR4, PRDM1, and CXCL2. ST2, however, was not detectable on omental AT Tregs from lean or obese subjects. This is the first comprehensive investigation into how omental AT immunity changes with obesity and T2D in humans, revealing important similarities and differences to paradigms in mice. These data increase our understanding of how pathways of immune regulation could be targeted to ameliorate AT inflammation in humans.
1,25-Dihydroxyvitamin D-3 increases the methionine cycle, CD4(+) T cell DNA methylation and Helios(+) Foxp3(+) T regulatory cells to reverse autoimmune Check for neurodegenerative disease
JOURNAL OF NEUROIMMUNOLOGY
Authors: Moore, Jerott R.; Hubler, Shane L.; Nelson, Corwin D.; Nashold, Faye E.; Spanier, Justin A.; Hayes, Colleen E.
Abstract
We investigated how one calcitriol dose plus vitamin D3 reverses experimental autoimmune encephalomyelitis (EAE), a multiple sclerosis model. This protocol rapidly increased CD4(+) T cell Ikzf2 transcripts, Helios protein, and CD4(+) Helios(+) FoxP3 T regulatory cells. It also rapidly increased CD4(+) T cell Bhmtl transcripts, betaine:homocysteine methyltransferase-1 (BHMT1) enzyme activity, and global DNA methylation. BHMT1 transmethylates homocysteine to replenish methionine. Targeting the Vdr gene in T cells decreased Ikzf2 and Bhmtl gene expression, reduced DNA methylation, and elevated systemic homocysteine in mice with EAE. We hypothesize that calcitriol drives a transition from encephalitogenic CD4(+) T cell to Treg cell dominance by upregulating Ikzf2 and Bhmtl, recycling homocysteine to methionine, reducing homocysteine toxicity, maintaining DNA methylation, and stabilizing CD4(+) Helios(+) FoxP3(+) Tregulatory cells. Conserved vitamin D-responsive element (VDRE)-type sequences in the Bhmtl and Ikzf2 promoters, the universal need for methionine in epigenetic regulation, and betaine's protective effects in MTHFR-deficiency suggest similar regulatory mechanisms exist in humans.